Arctoris, Molecule join forces on drug discovery
Arctoris has announced a new partnership with Molecule, in order to tackle the ongoing innovation crisis faced by drug discovery and development across both industry and academia.
The company says that through its fully automated drug discovery platform, Arctoris enables researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays. Which, together with Molecule’s distributed IP ownership platform, means they can take “critical strides” towards making drug discovery and development faster, cheaper, less risk-prone, and more viable at all levels.
Read more: https://lnkd.in/dPS66RG
The company says that through its fully automated drug discovery platform, Arctoris enables researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays. Which, together with Molecule’s distributed IP ownership platform, means they can take “critical strides” towards making drug discovery and development faster, cheaper, less risk-prone, and more viable at all levels.
Read more: https://lnkd.in/dPS66RG
